DK3660073T3 - Poly(lactid-co-glycolid) med lav sprængning - Google Patents

Poly(lactid-co-glycolid) med lav sprængning Download PDF

Info

Publication number: DK3660073T3
Authority: DK; Denmark
Prior art keywords: glycolide; lactide; poly; low blasting; blasting
Prior art date: 2007-02-15

Application number

DK19203071.6T

Other languages

English (en)

Inventor

Eric Dadey

John Middleton

Richard L Norton

Original Assignee

Tolmar International Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-15

Filing date

2008-02-13

Publication date

2023-09-18

2008-02-13 Application filed by Tolmar International Ltd filed Critical Tolmar International Ltd

2023-09-18 Application granted granted Critical

2023-09-18 Publication of DK3660073T3 publication Critical patent/DK3660073T3/da

Links

238000005422 blasting Methods 0.000 title 1
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/88—Post-polymerisation treatment
- C08G63/90—Purification; Drying
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Immunology (AREA)
Polymers & Plastics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Neurology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Pregnancy & Childbirth (AREA)

DK19203071.6T 2007-02-15 2008-02-13 Poly(lactid-co-glycolid) med lav sprængning DK3660073T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90143507P	2007-02-15	2007-02-15
EP15185218.3A EP3202814B1 (en)	2007-02-15	2008-02-13	Low burst poly-(lactide/glycolide) and methods to produce polymers

Publications (1)

Publication Number	Publication Date
DK3660073T3 true DK3660073T3 (da)	2023-09-18

Family

ID=39504385

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK19203071.6T DK3660073T3 (da)	2007-02-15	2008-02-13	Poly(lactid-co-glycolid) med lav sprængning
DK08725511.3T DK2115029T3 (da)	2007-02-15	2008-02-13	Lavsprængning poly-(laktid/glykolid) og fremgangsmåder til at fremstille polymerer
DK15185218T DK3202814T3 (da)	2007-02-15	2008-02-13	Poly-(laktid/glykolid) med lav udskilning og fremgangsmåder til at fremstille polymerer

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK08725511.3T DK2115029T3 (da)	2007-02-15	2008-02-13	Lavsprængning poly-(laktid/glykolid) og fremgangsmåder til at fremstille polymerer
DK15185218T DK3202814T3 (da)	2007-02-15	2008-02-13	Poly-(laktid/glykolid) med lav udskilning og fremgangsmåder til at fremstille polymerer

Country Status (15)

Country	Link
US (7)	US9187593B2 (da)
EP (3)	EP3202814B1 (da)
JP (3)	JP5342459B2 (da)
CA (1)	CA2678350C (da)
CY (2)	CY1116785T1 (da)
DK (3)	DK3660073T3 (da)
ES (3)	ES2550014T3 (da)
FI (1)	FI3660073T3 (da)
HR (3)	HRP20231117T3 (da)
HU (3)	HUE047775T2 (da)
LT (2)	LT3202814T (da)
PL (3)	PL3202814T3 (da)
PT (3)	PT3202814T (da)
SI (3)	SI3660073T1 (da)
WO (1)	WO2008100532A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8313763B2 (en)	2004-10-04	2012-11-20	Tolmar Therapeutics, Inc.	Sustained delivery formulations of rapamycin compounds
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
AU2007207618B2 (en)	2006-01-18	2011-03-24	Foresee Pharmaceuticals Co., Ltd.	Pharmaceutical compositions with enhanced stability
DK3660073T3 (da)	2007-02-15	2023-09-18	Tolmar International Ltd	Poly(lactid-co-glycolid) med lav sprængning
BRPI0811319A2 (pt) *	2007-05-25	2015-02-10	Tolmar Therapeutics Inc	Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento
AU2009255675B2 (en)	2008-06-03	2014-10-09	Tolmar Therapeutics, Inc.	Controlled release copolymer formulation with improved release kinetics
US10335366B2 (en)	2010-05-31	2019-07-02	Laboratorios Farmacéuticos Rovi, S.A.	Risperidone or paliperidone implant formulation
US10350159B2 (en)	2010-05-31	2019-07-16	Laboratories Farmacéuticos Rovi, S.A.	Paliperidone implant formulation
US10285936B2 (en)	2010-05-31	2019-05-14	Laboratorios Farmacéuticos Rovi, S.A.	Injectable composition with aromatase inhibitor
SI2394663T1 (sl)	2010-05-31	2022-02-28	Laboratorios Farmaceuticos Rovi, S.A.	Sestave za injicirane biološko razgradljive vsadke in situ
US10463607B2 (en)	2010-05-31	2019-11-05	Laboratorios Farmaceutics Rofi S.A.	Antipsychotic Injectable Depot Composition
ES2589106T3 (es)	2010-05-31	2016-11-10	Laboratorios Farmaceuticos Rovi, S.A.	Composición inyectable antipsicótica de liberación controlada
US10881605B2 (en)	2010-05-31	2021-01-05	Laboratorios Farmaceuticos Rovi, S.A.	Methods for the preparation of injectable depot compositions
US9272044B2 (en)	2010-06-08	2016-03-01	Indivior Uk Limited	Injectable flowable composition buprenorphine
GB2513267B (en)	2010-06-08	2015-03-18	Rb Pharmaceuticals Ltd	Injectable flowable composition comprising buprenorphine
GB2481017B (en)	2010-06-08	2015-01-07	Rb Pharmaceuticals Ltd	Microparticle buprenorphine suspension
CN103421172B (zh) *	2012-05-23	2016-01-20	上海现代药物制剂工程研究中心有限公司	一种生物可降解聚酯的纯化工艺
US20140308352A1 (en)	2013-03-11	2014-10-16	Zogenix Inc.	Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
EP2986278A1 (en)	2013-03-11	2016-02-24	DURECT Corporation	Injectable controlled release composition comprising high viscosity liquid carrier
JP5959728B2 (ja) *	2013-04-11	2016-08-02	三井化学株式会社	乳酸―グリコール酸共重合体の製造法またはその塩の製造法
EP3076948B1 (en) *	2013-12-06	2020-11-18	Allergan, Inc.	Intracameral implant for treatment of an ocular condition
GB201404139D0 (en)	2014-03-10	2014-04-23	Rb Pharmaceuticals Ltd	Sustained release buprenorphine solution formulations
US20160106804A1 (en) *	2014-10-15	2016-04-21	Yuhua Li	Pharmaceutical composition with improved stability
NZ731309A (en)	2014-11-07	2022-02-25	Indivior Uk Ltd	Buprenorphine dosing regimens
WO2017062770A1 (en)	2015-10-08	2017-04-13	Silverberg Noah	Punctal plug and bioadhesives
US10646484B2 (en)	2017-06-16	2020-05-12	Indivior Uk Limited	Methods to treat opioid use disorder
CN108498456B (zh) *	2018-05-16	2021-01-01	丽珠医药集团股份有限公司	一种阿立哌唑缓释微球及其制备方法
PE20210047A1 (es)	2018-06-12	2021-01-08	Farm Rovi Lab Sa	Composicion inyectable
EP3975990A1 (en) *	2019-05-27	2022-04-06	Tolmar International Limited	Leuprolide acetate compositions and methods of using the same to treat breast cancer
WO2021158968A1 (en)	2020-02-06	2021-08-12	Ocular Therapeutix, Inc.	Compositions and methods for treating ocular diseases
CA3177005A1 (en)	2020-04-27	2021-11-04	Michael Goldstein	Methods of treating allergic conjunctivitis
BR112023005807A2 (pt)	2020-09-30	2023-05-02	Tolmar International Ltd	Sistema de liberação de polímero biodegradável para liberação prolongada de testosterona
US12318387B2 (en)	2021-07-16	2025-06-03	Laboratorios Farmaceuticos Rovi, S.A.	Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
US12594236B2 (en)	2021-07-16	2026-04-07	Laboratorios Farmaceuticos Rovi, S.A.	Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
KR102785339B1 (ko) *	2021-08-27	2025-03-21	주식회사 엘지화학	블록 공중합체 및 이의 제조 방법
WO2024168022A2 (en)	2023-02-10	2024-08-15	Tolmar, Inc.	Degarelix polymeric formulations
WO2025008759A1 (en)	2023-07-05	2025-01-09	Tolmar International Limited	Polymeric leuprolide acetate formulations

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2551756B2 (ja)	1985-05-07	1996-11-06	武田薬品工業株式会社	ポリオキシカルボン酸エステルおよびその製造法
DE3641692A1 (de)	1986-12-06	1988-06-09	Boehringer Ingelheim Kg	Katalysatorfreie resorbierbare homopolymere und copolymere
DE3708916A1 (de)	1987-03-19	1988-09-29	Boehringer Ingelheim Kg	Verfahren zur reinigung resorbierbarer polyester
US4938763B1 (en)	1988-10-03	1995-07-04	Atrix Lab Inc	Biodegradable in-situ forming implants and method of producing the same
US5702716A (en)	1988-10-03	1997-12-30	Atrix Laboratories, Inc.	Polymeric compositions useful as controlled release implants
US5487897A (en)	1989-07-24	1996-01-30	Atrix Laboratories, Inc.	Biodegradable implant precursor
US5324519A (en)	1989-07-24	1994-06-28	Atrix Laboratories, Inc.	Biodegradable polymer composition
EP0452111B1 (en)	1990-04-13	1998-07-15	Takeda Chemical Industries, Ltd.	Biodegradable high-molecular polymers, production and use thereof
USRE37950E1 (en)	1990-04-24	2002-12-31	Atrix Laboratories	Biogradable in-situ forming implants and methods of producing the same
US6353030B1 (en) *	1990-08-01	2002-03-05	Novartis Ag	Relating to organic compounds
AU2605592A (en)	1991-10-15	1993-04-22	Atrix Laboratories, Inc.	Polymeric compositions useful as controlled release implants
EP0560014A1 (en)	1992-03-12	1993-09-15	Atrix Laboratories, Inc.	Biodegradable film dressing and method for its formation
US5681873A (en)	1993-10-14	1997-10-28	Atrix Laboratories, Inc.	Biodegradable polymeric composition
ES2258495T3 (es)	1994-04-08	2006-09-01	Qlt Usa, Inc.	Composiciones de administracion liquida de farmacos.
PT814778E (pt)	1995-03-10	2001-11-30	Roche Diagnostics Gmbh	Formas de administracao farmaceuticas contendo polipeptidos sob a forma de microparticulas e processo para a sua preparacao
US5736152A (en)	1995-10-27	1998-04-07	Atrix Laboratories, Inc.	Non-polymeric sustained release delivery system
US6264970B1 (en)	1996-06-26	2001-07-24	Takeda Chemical Industries, Ltd.	Sustained-release preparation
JP4317599B2 (ja) *	1996-06-26	2009-08-19	武田薬品工業株式会社	徐放性製剤
AU736812B2 (en)	1997-10-03	2001-08-02	Btg International Limited	Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6261583B1 (en)	1998-07-28	2001-07-17	Atrix Laboratories, Inc.	Moldable solid delivery system
US6565874B1 (en)	1998-10-28	2003-05-20	Atrix Laboratories	Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en)	1998-10-28	2000-11-07	Atrix Laboratories, Inc.	Controlled release liquid delivery compositions with low initial drug burst
US6355657B1 (en)	1998-12-30	2002-03-12	Atrix Laboratories, Inc.	System for percutaneous delivery of opioid analgesics
US6461631B1 (en)	1999-11-16	2002-10-08	Atrix Laboratories, Inc.	Biodegradable polymer composition
US7019106B2 (en) *	2000-08-07	2006-03-28	Wako Pure Chemical Industries, Ltd.	Lactic acid polymer and process for producing the same
JP5188670B2 (ja) *	2001-06-29	2013-04-24	武田薬品工業株式会社	徐放性組成物およびその製造法
TWI225416B (en)	2001-06-29	2004-12-21	Takeda Chemical Industries Ltd	Sustained-release composition and process for producing the same
US20060034889A1 (en) *	2004-08-16	2006-02-16	Macromed, Inc.	Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
WO2006041942A2 (en) *	2004-10-04	2006-04-20	Qlt Usa, Inc.	Ocular delivery of polymeric delivery formulations
EP1824460B1 (en)	2004-11-10	2014-12-24	Tolmar Therapeutics, Inc.	A stabilized polymeric delivery system
ES2516695T3 (es) *	2006-10-11	2014-10-31	Tolmar Therapeutics, Inc.	Preparación de poliésteres biodegradables con bajas propiedades de absorción rápida mediante extracción de fluido supercrítico
DK3660073T3 (da)	2007-02-15	2023-09-18	Tolmar International Ltd	Poly(lactid-co-glycolid) med lav sprængning

2008
- 2008-02-13 DK DK19203071.6T patent/DK3660073T3/da active
- 2008-02-13 HU HUE15185218A patent/HUE047775T2/hu unknown
- 2008-02-13 SI SI200832213T patent/SI3660073T1/sl unknown
- 2008-02-13 WO PCT/US2008/001887 patent/WO2008100532A1/en not_active Ceased
- 2008-02-13 SI SI200831512T patent/SI2115029T1/sl unknown
- 2008-02-13 HR HRP20231117TT patent/HRP20231117T3/hr unknown
- 2008-02-13 CA CA2678350A patent/CA2678350C/en not_active Expired - Fee Related
- 2008-02-13 LT LT15185218T patent/LT3202814T/lt unknown
- 2008-02-13 FI FIEP19203071.6T patent/FI3660073T3/fi active
- 2008-02-13 EP EP15185218.3A patent/EP3202814B1/en active Active
- 2008-02-13 ES ES08725511.3T patent/ES2550014T3/es active Active
- 2008-02-13 PT PT151852183T patent/PT3202814T/pt unknown
- 2008-02-13 PT PT192030716T patent/PT3660073T/pt unknown
- 2008-02-13 PL PL15185218T patent/PL3202814T3/pl unknown
- 2008-02-13 SI SI200832098T patent/SI3202814T1/sl unknown
- 2008-02-13 DK DK08725511.3T patent/DK2115029T3/da active
- 2008-02-13 DK DK15185218T patent/DK3202814T3/da active
- 2008-02-13 US US12/527,377 patent/US9187593B2/en not_active Expired - Fee Related
- 2008-02-13 JP JP2009550095A patent/JP5342459B2/ja active Active
- 2008-02-13 ES ES19203071T patent/ES2956244T3/es active Active
- 2008-02-13 LT LTEP19203071.6T patent/LT3660073T/lt unknown
- 2008-02-13 HR HRP20150997TT patent/HRP20150997T1/hr unknown
- 2008-02-13 ES ES15185218T patent/ES2755374T3/es active Active
- 2008-02-13 PL PL08725511T patent/PL2115029T3/pl unknown
- 2008-02-13 HU HUE19203071A patent/HUE063170T2/hu unknown
- 2008-02-13 HU HUE08725511A patent/HUE025842T2/en unknown
- 2008-02-13 EP EP08725511.3A patent/EP2115029B1/en active Active
- 2008-02-13 PL PL19203071.6T patent/PL3660073T3/pl unknown
- 2008-02-13 EP EP19203071.6A patent/EP3660073B1/en active Active
- 2008-02-13 PT PT87255113T patent/PT2115029E/pt unknown
2013
- 2013-08-09 JP JP2013166807A patent/JP5848290B2/ja active Active
2015
- 2015-04-10 JP JP2015080726A patent/JP6195587B2/ja active Active
- 2015-10-08 CY CY20151100906T patent/CY1116785T1/el unknown
- 2015-10-27 US US14/924,243 patent/US9561282B2/en active Active
2016
- 2016-12-19 US US15/384,117 patent/US9655970B2/en active Active
2017
- 2017-04-18 US US15/490,615 patent/US9974824B2/en active Active
2018
- 2018-04-10 US US15/950,024 patent/US10206970B2/en active Active
2019
- 2019-01-08 US US16/242,316 patent/US11147880B2/en active Active
- 2019-11-14 HR HRP20192055TT patent/HRP20192055T1/hr unknown
- 2019-11-18 CY CY20191101209T patent/CY1122304T1/el unknown
2021
- 2021-09-16 US US17/477,361 patent/US11717572B2/en active Active

Also Published As

Publication number	Publication date
US20100292195A1 (en)	2010-11-18
ES2550014T3 (es)	2015-11-03
CY1122304T1 (el)	2021-01-27
FI3660073T3 (fi)	2023-09-11
JP5848290B2 (ja)	2016-01-27
EP3202814A1 (en)	2017-08-09
US9655970B2 (en)	2017-05-23
WO2008100532A1 (en)	2008-08-21
US11147880B2 (en)	2021-10-19
EP2115029B1 (en)	2015-09-16
CY1116785T1 (el)	2017-03-15
EP3660073B1 (en)	2023-07-12
LT3660073T (lt)	2023-10-10
US20170216395A1 (en)	2017-08-03
PT2115029E (pt)	2015-10-26
HUE025842T2 (en)	2016-04-28
US20180311305A1 (en)	2018-11-01
JP2013224339A (ja)	2013-10-31
PT3202814T (pt)	2019-11-26
PL3202814T3 (pl)	2020-01-31
PL3660073T3 (pl)	2023-12-27
EP3202814B1 (en)	2019-10-16
US20220202941A1 (en)	2022-06-30
JP2010519218A (ja)	2010-06-03
CA2678350A1 (en)	2008-08-21
PT3660073T (pt)	2023-08-31
US20190209643A1 (en)	2019-07-11
JP2015127351A (ja)	2015-07-09
EP2115029A1 (en)	2009-11-11
CA2678350C (en)	2015-11-17
US10206970B2 (en)	2019-02-19
SI3202814T1 (sl)	2019-12-31
US9561282B2 (en)	2017-02-07
DK3202814T3 (da)	2019-11-25
SI2115029T1 (sl)	2016-01-29
PL2115029T3 (pl)	2016-01-29
HK1138303A1 (en)	2010-08-20
DK2115029T3 (da)	2015-10-05
US20160106847A1 (en)	2016-04-21
HRP20192055T1 (hr)	2020-02-21
SI3660073T1 (sl)	2023-10-30
US20170095560A1 (en)	2017-04-06
US9187593B2 (en)	2015-11-17
HRP20231117T3 (hr)	2023-12-22
HUE063170T2 (hu)	2024-01-28
ES2956244T3 (es)	2023-12-15
JP6195587B2 (ja)	2017-09-13
US11717572B2 (en)	2023-08-08
JP5342459B2 (ja)	2013-11-13
ES2755374T3 (es)	2020-04-22
LT3202814T (lt)	2019-12-10
EP3660073A1 (en)	2020-06-03
US9974824B2 (en)	2018-05-22
HRP20150997T1 (hr)	2015-12-18
HUE047775T2 (hu)	2020-05-28

Publication	Publication Date	Title
SI3660073T1 (sl)	2023-10-30	Poli (laktid-co-glikolid) z nizkim izpadom
IL246421A0 (en)	2016-08-31	Self-expanding devices
DE602007009217D1 (de)	2010-10-28	Schaltung
BRPI0820493A2 (pt)	2015-06-16	Modo de descanso para dispositivo de comunicação móvel.
LU92600I2 (fr)	2015-11-24	Sovaldi (sofosbuvir)
DK2182863T3 (da)	2012-07-16	Åbningsdilatator
HRP20151058T1 (xx)	2015-12-04	Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
DK2130417T3 (da)	2019-05-27	Printplader
ATE513831T1 (de)	2011-07-15	Pyridinä3,4-büpyrazinone
DK3348232T3 (da)	2020-05-18	Stentelement
EP2173353A4 (en)	2012-05-02	Transplants
DE502006009368D1 (de)	2011-06-01	Zwitterionische strukturelemente aufweisende partikel
EP2037942A4 (en)	2012-04-25	POLYMER biosurfactants
DE602006009894D1 (de)	2009-12-03	Verbesserter Flash-ADC
BRPI0812916A2 (pt)	2014-12-09	Chupeta
EP2115033A4 (en)	2012-04-04	POLYURETHANE
EP2184303A4 (en)	2011-01-12	Copolymer
DE112008000295A5 (de)	2009-10-29	Steckerstift
ATE506032T1 (de)	2011-05-15	Endoprothesenkomponente
FI20075004L (fi)	2008-07-05	Antennirakenne
ATE519751T1 (de)	2011-08-15	Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate
EP2120334A4 (en)	2012-11-07	demodulation circuit
DE602008002359D1 (de)	2010-10-14	Empfangsschaltung
FI20065536L (fi)	2008-03-01	Lukitusjärjestely
EP2223113A4 (en)	2011-04-06	CIRCULATING RET RECEPTOR